422 results on '"Pérez-Molina, José A"'
Search Results
2. Fecal microbiota transplantation alters the proteomic landscape of inflammation in HIV: identifying bacterial drivers
3. Identification of Chagas disease biomarkers using untargeted metabolomics
4. Author Correction: Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach
5. Screening blood donors for malaria, can we increase the number of eligible donors? An observational retrospective study
6. Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach
7. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up
8. Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi study
9. Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial
10. Study on the approach to HIV: health management and the healthcare process in Spain
11. Estudio sobre la aproximación al VIH: gestión sanitaria y el proceso asistencial en España
12. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
13. Fecal Microbiota Transplantation Alters the Proteomic Landscape of Inflammation in HIV: Identifying Bacterial Drivers
14. Executive summary of the consensus document of the HIV quality of care indicators. GESIDA updated
15. Trypanocidal treatment of Chagas disease
16. Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study
17. Chagas disease is related to structural changes of the gut microbiota in adults with chronic infection (TRIPOBIOME Study)
18. Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV
19. Screening blood donors for malaria, can we increase the number of eligible donors? An observational retrospective study.
20. Understanding clinical decision-making during the COVID-19 pandemic: A cross-sectional worldwide survey
21. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
22. Corrigendum: CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis
23. CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis
24. Are we on track to achieve the UNAIDS goals by 2030 for people with HIV in Spain?
25. Fecal microbiota transplantation in HIV: A pilot placebo-controlled study
26. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults
27. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)
28. COVID-19 and geographical area of origin
29. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults
30. Chagas disease
31. Eosinophilia prevalence and related factors in travel and immigrants of the network +REDIVI
32. Prevalencia de la eosinofilia y factores relacionados en los viajeros e inmigrantes de la red +REDIVI
33. Chagas disease is related to structural changes of the gut microbiota in adults with chronic infection (TRIPOBIOME Study)
34. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults
35. Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis
36. Rickettsioses imported by travellers and migrants to Spain attended in the +Redivi network, 2009–2020
37. Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer
38. How the microbiome can help detect precancerous lesions and prevent anal cancer
39. Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
40. Characteristics of HIV infected individuals traveling abroad. Results from the +REDIVI Collaborative Network
41. ¿Cómo está afectando la aplicación del nuevo marco legal sanitario a la asistencia de los inmigrantes infectados por el VIH en situación irregular en España?
42. Diagnóstico y tratamiento de la malaria importada en España: recomendaciones del Grupo de Trabajo de Malaria de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI)
43. Screening of imported malaria infection in asymptomatic migrants from Sub-Saharan Africa: A retrospective analysis of a 2010–2019 cohort
44. Estudio sobre la aproximación al VIH: gestión sanitaria y el proceso asistencial en España
45. 6-year review of +Redivi: a prospective registry of imported infectious diseases in Spain
46. Migration and the geography of disease
47. Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV
48. Concerns About Topical Treatment for New World Cutaneous Leishmanisis
49. Relationship of Diet to Gut Microbiota and Inflammatory Biomarkers in People with HIV
50. HIV, HPV, and microbiota: partners in crime?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.